Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotrosen

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Psychopharmacology|December 19, 1977
Dopaminergic agonist properties of ephedrine--theoretical implicationsB Angrist, J Rotrosen, D Kleinberg, et al.
Psychopharmacology|January 1, 1982
Partial improvement in negative schizophrenic symptoms after amphetamineB Angrist, E Peselow, M Rubinstein, et al.
The Journal of Clinical Psychiatry|January 1, 1989
Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patientsS Reiter, L Adler, B Angrist, et al.
The American Journal of Psychiatry|February 1, 1989
Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlatesR Douyon, B Angrist, E Peselow, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1982
Piracetam reduces alcohol withdrawal in mice without potentiating alcohol sedative effectsM Serby, D J Segarnick, D M Cordasco, et al.
Journal of Clinical Psychopharmacology|June 1, 1985
Efficacy of propranolol in neuroleptic-induced akathesiaL Adler, B Angrist, E Peselow, et al.
Psychopharmacology Bulletin|January 1, 1981
Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings]J Rotrosen, M Stanley, A Lautin, et al.
Lancet (London, England)|December 1, 1979
Tardive dyskinesia and metoclopramideM Stanley, J Rotrosen, A Lautin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1985
Olfaction in dementiaM Serby, J Corwin, A Novatt, et al.
Journal of Clinical Psychopharmacology|August 1, 1987
Atenolol and propranolol in neuroleptic-induced akathisiaS Reiter, L Adler, B Angrist, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Psychopharmacology|December 19, 1977
Dopaminergic agonist properties of ephedrine--theoretical implicationsB Angrist, J Rotrosen, D Kleinberg, et al.
Psychopharmacology|January 1, 1982
Partial improvement in negative schizophrenic symptoms after amphetamineB Angrist, E Peselow, M Rubinstein, et al.
The Journal of Clinical Psychiatry|January 1, 1989
Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patientsS Reiter, L Adler, B Angrist, et al.
The American Journal of Psychiatry|February 1, 1989
Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlatesR Douyon, B Angrist, E Peselow, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1982
Piracetam reduces alcohol withdrawal in mice without potentiating alcohol sedative effectsM Serby, D J Segarnick, D M Cordasco, et al.
Journal of Clinical Psychopharmacology|June 1, 1985
Efficacy of propranolol in neuroleptic-induced akathesiaL Adler, B Angrist, E Peselow, et al.
Psychopharmacology Bulletin|January 1, 1981
Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings]J Rotrosen, M Stanley, A Lautin, et al.
Lancet (London, England)|December 1, 1979
Tardive dyskinesia and metoclopramideM Stanley, J Rotrosen, A Lautin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1985
Olfaction in dementiaM Serby, J Corwin, A Novatt, et al.
Journal of Clinical Psychopharmacology|August 1, 1987
Atenolol and propranolol in neuroleptic-induced akathisiaS Reiter, L Adler, B Angrist, et al.
Pageof 13